Published in Sleep on September 15, 1998
Association between metabolic syndrome and sleep-disordered breathing in adolescents. Am J Respir Crit Care Med (2007) 1.98
Sleep and immune function. Pflugers Arch (2011) 1.76
A six-month randomized controlled trial of exercise and pyridostigmine in the treatment of fibromyalgia. Arthritis Rheum (2008) 1.55
Pathophysiology of fibromyalgia. Am J Med (2009) 1.47
Phylogenetic analysis of the ecology and evolution of mammalian sleep. Evolution (2008) 1.33
AutoDecon: a robust numerical method for the quantification of pulsatile events. Methods Enzymol (2009) 1.33
Evidence for acyl-ghrelin modulation of growth hormone release in the fed state. J Clin Endocrinol Metab (2008) 1.15
Fibromyalgia syndrome: etiology, pathogenesis, diagnosis, and treatment. Pain Res Treat (2012) 1.15
Obesity and obesity related co-morbidities in a referral population of children with asthma. Pediatr Pulmonol (2009) 0.99
The role of ghrelin in GH secretion and GH disorders. Mol Cell Endocrinol (2011) 0.88
Ablation of leptin signaling to somatotropes: changes in metabolic factors that cause obesity. Endocrinology (2012) 0.87
Insights into puberty: the relationship between sleep stages and pulsatile LH secretion. J Clin Endocrinol Metab (2012) 0.84
Randomised controlled trial of the effects of L-ornithine on stress markers and sleep quality in healthy workers. Nutr J (2014) 0.81
Microarchitecture, but not bone mechanical properties, is rescued with growth hormone treatment in a mouse model of growth hormone deficiency. Int J Endocrinol (2012) 0.80
A 24-Hour Study of the Hypothalamo-Pituitary Axes in Huntington's Disease. PLoS One (2015) 0.79
Sleep disturbances, daytime sleepiness, and quality of life in adults with growth hormone deficiency. J Clin Endocrinol Metab (2010) 0.77
Central Nervous Insulin Signaling in Sleep-Associated Memory Formation and Neuroendocrine Regulation. Neuropsychopharmacology (2015) 0.77
Recovery sleep does not mitigate the effects of prior sleep loss on paclitaxel-induced mechanical hypersensitivity in Sprague-Dawley rats. Biol Res Nurs (2014) 0.76
Pharmacokinetics and pharmacodynamics of PF-05190457: The first oral ghrelin receptor inverse agonist to be profiled in healthy subjects. Br J Clin Pharmacol (2016) 0.75
Metabolic signals in sleep regulation: recent insights. Nat Sci Sleep (2016) 0.75
Impact of GH replacement therapy on sleep in adult patients with GH deficiency of pituitary origin. Eur J Endocrinol (2013) 0.75
[Fibromyalgia]. Z Rheumatol (2011) 0.75
Rhythms in the endocrine system of fish: a review. J Comp Physiol B (2017) 0.75
Age-related changes in slow wave sleep and REM sleep and relationship with growth hormone and cortisol levels in healthy men. JAMA (2000) 4.14
Sleep loss results in an elevation of cortisol levels the next evening. Sleep (1997) 2.61
Adaptation of the 24-h growth hormone profile to a state of sleep debt. Am J Physiol Regul Integr Comp Physiol (2000) 1.49
Growth hormone assays: early to latest test generations compared. Clin Chem (1996) 1.40
Patterns of plasma levels of prednisolone after oral administration in man. J Pharmacokinet Biopharm (1974) 1.37
The 24-hour profile of adrenocorticotropin and cortisol in major depressive illness. J Clin Endocrinol Metab (1985) 1.37
Prolactin release after injection of thyrotrophin-releasing hormone in man. Lancet (1972) 1.23
Simultaneous stimulation of slow-wave sleep and growth hormone secretion by gamma-hydroxybutyrate in normal young Men. J Clin Invest (1997) 1.21
24-hour profiles of adrenocorticotropin, cortisol, and growth hormone in major depressive illness: effect of antidepressant treatment. J Clin Endocrinol Metab (1987) 1.18
Relationships between sleep quality and glucose regulation in normal humans. Am J Physiol (1996) 1.18
Effects of "jet lag" on hormonal patterns. IV. Time shifts increase growth hormone release. J Clin Endocrinol Metab (1983) 1.11
A quantitative estimation of growth hormone secretion in normal man: reproducibility and relation to sleep and time of day. J Clin Endocrinol Metab (1992) 1.05
Quantitative analysis of spontaneous variations of plasma prolactin in normal man. Am J Physiol (1981) 1.05
Effects of "jet lag" on hormonal patterns. I. Procedures, variations in total plasma proteins, and disruption of adrenocorticotropin-cortisol periodicity. J Clin Endocrinol Metab (1981) 1.03
Insulin-like growth factor I: a good indicator of functional hepatocellular capacity in alcoholic liver cirrhosis. J Endocrinol Invest (1991) 1.01
[Determination by competition of plasma corticol. Modification of Murphy's method]. Rev Fr Etud Clin Biol (1969) 0.98
Rapid phase advance of the 24-h melatonin profile in response to afternoon dark exposure. Am J Physiol (1998) 0.97
The 24-hour profiles of cortisol, prolactin, and growth hormone secretion in mania. Arch Gen Psychiatry (1994) 0.97
Cortisol secretion during acute bacterial infections in man. Acta Endocrinol (Copenh) (1968) 0.97
Role of fat-derived substrates in the regulation of gluconeogenesis during fasting. Am J Physiol (1996) 0.94
Effect of arginine on serum levels of insulin and growth hormone in obese subjects. Metabolism (1967) 0.93
Effects of "jet lag" on hormonal patterns. II. Adaptation of melatonin circadian periodicity. J Clin Endocrinol Metab (1981) 0.91
Circadian and sleep-related endocrine rhythms in schizophrenia. Arch Gen Psychiatry (1991) 0.91
Interrelationships between growth hormone and sleep. Growth Horm IGF Res (2000) 0.91
Regulation of maternal IGF-I by placental GH in normal and abnormal human pregnancies. Am J Physiol (1993) 0.91
Physiology of growth hormone secretion during sleep. J Pediatr (1996) 0.89
A benzodiazepine hypnotic facilitates adaptation of circadian rhythms and sleep-wake homeostasis to an eight hour delay shift simulating westward jet lag. Sleep (2000) 0.89
Alterations of circadian rhythmicity and sleep in aging: endocrine consequences. Horm Res (1998) 0.88
Seasonal, circadian and episodic variations of human immunoreactive beta-MSH, ACTH and cortisol. Int J Pept Protein Res (1981) 0.87
The endocrinometabolic effects of beclomethasone dipropionate in asthmatic patients. Chest (1977) 0.86
Radioimmunoassay of human growth hormone using a charcoal-dextran separation procedure. Clin Chim Acta (1971) 0.85
Two years of replacement therapy in adults with growth hormone deficiency. Clin Endocrinol (Oxf) (1997) 0.84
Cortisol secretion rate and urinary corticoid excretion in normal and obese subjects. Acta Endocrinol (Copenh) (1966) 0.84
Effect of various blood sampling procedures on serum levels of immunoreactive human growth hormone. Metabolism (1967) 0.84
Effects of glucocorticoids on pituitary hormonal responses to hypoglycemia. Inhibition of prolactin release. J Clin Endocrinol Metab (1975) 0.84
Sleep-promoting effects of growth hormone-releasing hormone in normal men. Am J Physiol (1993) 0.84
Prolactin secretion in Cushing's disease. J Clin Endocrinol Metab (1981) 0.82
Effects of metformin on the pathways of glucose utilization after oral glucose in non-insulin-dependent diabetes mellitus patients. Metabolism (1997) 0.82
Adrenocortical and somatotrophic secretions in acute and chronic respiratory insufficiency. Am Rev Respir Dis (1975) 0.82
Physiological role of somatostatin on growth hormone regulation in humans. Metabolism (1990) 0.82
Regression of lung size in adults with growth hormone deficiency. Q J Med (1980) 0.81
Relations between immunoreactive somatomedin C, insulin and T3 patterns during fasting in obese subjects. Clin Endocrinol (Oxf) (1984) 0.81
Dwarfism caused by cushing's syndrome. Acta Endocrinol (Copenh) (1969) 0.81
Progressive elevation of plasma thyrotropin during adaptation to simulated jet lag: effects of treatment with bright light or zolpidem. J Clin Endocrinol Metab (1996) 0.80
ACTH, cortisol and growth hormone 24-hour profiles in major depressive illness. Acta Psychiatr Belg (1986) 0.80
Placental growth hormone as a potential regulator of maternal IGF-I during human pregnancy. Am J Physiol (1990) 0.80
Level of glycogen stores and amount of ingested glucose regulate net carbohydrate storage by different mechanisms. Metabolism (2003) 0.80
Impaired counterregulation of glucose in a patient with hypothalamic sarcoidosis. N Engl J Med (1999) 0.80
Sleep, awakenings, and insulin-like growth factor-I modulate the growth hormone (GH) secretory response to GH-releasing hormone. J Clin Endocrinol Metab (1992) 0.79
Circadian and ultradian variations of ACTH and cortisol secretion. Horm Res (1980) 0.79
Insulin-like growth factor I values in patients on maintenance hemodialysis: relationship to growth hormone and albumin levels. J Endocrinol Invest (1993) 0.78
Effects of "jet lag" on hormonal patterns. III. Demonstration of an intrinsic circadian rhythmicity in plasma prolactin. J Clin Endocrinol Metab (1982) 0.78
Hyperglycemic response to intravenous arginine in prematurity-onset diabetes. Diabetes (1967) 0.78
Acute endocrine profile of sulpiride in the human. Clin Endocrinol (Oxf) (1978) 0.78
Nocturnal elevation of glucose levels during fasting in noninsulin-dependent diabetes. J Clin Endocrinol Metab (1991) 0.78
Diurnal hypersecretion of growth hormone in depression. J Clin Endocrinol Metab (1985) 0.77
Effect of fasting on the intracellular metabolic partition of intravenously infused glucose in humans. Am J Physiol (1999) 0.77
Somatomedins and steroids. Horm Res (1986) 0.77
Evidence against a role for the growth hormone-releasing peptide axis in human slow-wave sleep regulation. Am J Physiol (1998) 0.77
Extra-adrenal actions of metyrapone in man. Effects on plasma cortisol disappearance, growth hormone secretion and glucose metabolism. J Clin Endocrinol Metab (1971) 0.77
Pituitary and extrapituitary effects of somatostatin in normal man. Horm Metab Res (1976) 0.77
Genetic control of 24-hour growth hormone secretion in man: a twin study. J Clin Endocrinol Metab (1999) 0.77
Growth hormone-releasing hormone and growth hormone-releasing peptide as potential therapeutic modalities. Acta Paediatr Scand Suppl (1990) 0.76
Simultaneous study of cortisol, growth hormone and prolactin nyctohemeral variations in normal and obese subjects. Influence of prolonged fasting in obesity. Clin Endocrinol (Oxf) (1978) 0.76
Immediate and delayed alterations of adrenocorticotropin and cortisol nyctohemeral profiles after corticotropin-releasing factor in normal man. J Clin Endocrinol Metab (1983) 0.76
Symptomatic hypopituitarism revealing a primary empty sella turcica. Postgrad Med J (1981) 0.75
[Addison's disease and thyrotoxic crisis]. Presse Med (1969) 0.75
[Budd-Chiari syndrome due to adrenal gland cancer]. Acta Clin Belg (1967) 0.75
Transport of cortisol, progesterone and cholesterol across isolated mesentery. Effect of metyrapone. J Membr Biol (1973) 0.75
Prolactin response to hypoglycaemia. Lancet (1973) 0.75
Absence of relationship between induced changes in urine volume and cortisol secretion rate. Acta Endocrinol (Copenh) (1967) 0.75
[Action of calcium and parathyroid hormone on the excretion of electrolytes and urokinase in idiopathic parathyroid insufficiency]. J Urol Nephrol (Paris) (1969) 0.75
[Hypophyseal hormonal rhythm in a physiological state]. Probl Actuels Endocrinol Nutr (1975) 0.75
[Schmidt's syndrome and diabetes mellitus]. Acta Clin Belg (1969) 0.75
Acute effects of cold on blood levels of growth hormone, cortisol, and thyrotropin in man. J Appl Physiol (1970) 0.75
[Pituitary modifications in a case of Schilder disease (author's transl)]. Ann Endocrinol (Paris) (1977) 0.75
Reproducibility of plasma growth hormone determinations between different laboratories. Clin Chim Acta (1972) 0.75
Two-bromo- -ergocryptine (CB 154) inhibition of prolactin secretion and galactorrhoea in a case of pituitary tumour. Gynecol Invest (1971) 0.75
[A competitive radioisotope binding technic for the determination of prednisolone and of a new synthetic corticoid]. Pathol Biol (Paris) (1975) 0.75
Effects of dexamthasone and secobarbital on the pituitary response to thryotropin releasing hormone (TRH) in man: synergistic inhibition of thyrotropin (TSH) release. Neuroendocrinology (1974) 0.75
[Association of Addison's disease, diabetes and thyroid diseases: clinical, autoimmune, and genetic aspects]. Actual Endocrinol (Paris) (1973) 0.75
Effects of testosterone on gonadotrophin responses to synthetic LH and FSH releasing hormone (LRH) in normal men. Acta Endocrinol (Copenh) (1976) 0.75
Specific inhibition by somatostatin of growth hormone release after hypoglycaemia in normal man. Clin Endocrinol (Oxf) (1974) 0.75
[Cortisol secretion in hyperthyroidism]. C R Seances Soc Biol Fil (1968) 0.75
A new ACTH stimulation test using prior administration of dexamethasone and of secobarbital, and competitive protein binding estimation of plasma cortisol. Steroidologia (1970) 0.75
Modulation of immunoreactive somatomedin-C levels by sex steroids. Acta Endocrinol (Copenh) (1986) 0.75
[The action of physiologic doses of synthetic ACTH in normal man]. Arch Int Pharmacodyn Ther (1970) 0.75
Growth hormone response to rapid intravenous injection of various amounts of 1-24 ACTH. Horm Metab Res (1971) 0.75
[Sarcoma of the pericardium]. J Fr Med Chir Thorac (1966) 0.75
[Cushing's syndrome: review of the literature and 17 personal cases]. Brux Med (1969) 0.75
[The passage of cortisol across the hematomeningeal barrier in purulent meningitis and various coma cases without meningeal impairment]. Lyon Med (1972) 0.75
Response to tetracosactrin. Lancet (1969) 0.75
Adenocortical responsiveness to physiological amounts of 1-24 ACTH. I. Effect of prior administration of dexamethasone. Horm Metab Res (1972) 0.75
[Concealed hyperthyroidism in a patient adrenalectomized for Cushing's disease]. Ann Endocrinol (Paris) (1969) 0.75
Effects of altered thyroid function upon cortisol secretion in man. Horm Metab Res (1971) 0.75
Adrenocortical responsiveness to physiological amounts of 1-24 ACTH. II. Effect of acute corticotrophin treatment in patients receiving prolonged glucocorticoid therapy. Horm Metab Res (1972) 0.75
Measurement of cortisol secretion rate by isotope dilution techniques. J Nucl Biol Med (1972) 0.75
Monthly variations of serum levels of thyrotropin, growth hormone and cortisol in man. Horm Metab Res (1974) 0.75